128 related articles for article (PubMed ID: 1677029)
1. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
Hadjiconstantinou M; Fitkin JG; Dalia A; Neff NH
J Neurochem; 1991 Aug; 57(2):479-82. PubMed ID: 1677029
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
Mori S; Fujitake J; Kuno S; Sano Y
Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
[TBL] [Abstract][Full Text] [Related]
3. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
Mayer RA; Walters AS; Heikkila RE
Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908
[TBL] [Abstract][Full Text] [Related]
4. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
Park TH; Mytilineou C
Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
[TBL] [Abstract][Full Text] [Related]
5. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
Hadjiconstantinou M; Mariani AP; Neff NH
Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
[TBL] [Abstract][Full Text] [Related]
6. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
Johannessen JN; Sobotka TJ; Weise VK; Markey SP
J Neurochem; 1991 Sep; 57(3):981-90. PubMed ID: 1677682
[TBL] [Abstract][Full Text] [Related]
7. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L
Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379
[TBL] [Abstract][Full Text] [Related]
8. Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice.
Otto D; Unsicker K
J Neurosci; 1990 Jun; 10(6):1912-21. PubMed ID: 1972393
[TBL] [Abstract][Full Text] [Related]
9. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
10. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
12. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
Leng A; Mura A; Hengerer B; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
[TBL] [Abstract][Full Text] [Related]
13. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig.
Perry TL; Yong VW; Ito M; Jones K; Wall RA; Foulks JG; Wright JM; Kish SJ
Life Sci; 1985 Apr; 36(13):1233-8. PubMed ID: 2858797
[TBL] [Abstract][Full Text] [Related]
14. Dopamine differentiation factors increase striatal dopaminergic function in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mice.
Jin BK; Iacovitti L
J Neurosci Res; 1996 Feb; 43(3):331-4. PubMed ID: 8714521
[TBL] [Abstract][Full Text] [Related]
15. Embryonic dopaminergic neuron transplants in MPTP lesioned mouse striatum.
Di Porzio U; Zuddas A
Neurochem Int; 1992 Mar; 20 Suppl():309S-320S. PubMed ID: 1365448
[TBL] [Abstract][Full Text] [Related]
16. Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice.
Vaglini F; Pardini C; Bonuccelli U; Maggio R; Corsini GU
Brain Res; 2003 May; 973(2):298-302. PubMed ID: 12738074
[TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
18. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
Hadjiconstantinou M; Neff NH
J Neurochem; 1988 Oct; 51(4):1190-6. PubMed ID: 3262149
[TBL] [Abstract][Full Text] [Related]
19. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Holmer HK; Keyghobadi M; Moore C; Meshul CK
Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
[TBL] [Abstract][Full Text] [Related]
20. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.
Sanchez-Ramos J; Barrett JN; Goldstein M; Weiner WJ; Hefti F
Neurosci Lett; 1986 Dec; 72(2):215-20. PubMed ID: 2880321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]